Menu

Amgen headquarters

Amgen recently exempted Oregon providers from its 340B contract pharmacy restrictions but removed a prior exemption for New Mexico.

Amgen Exempts Oregon from 340B Contract Pharmacy Restrictions, but Drops New Mexico

February 20, 2026 William Newton, Associate Editor/Senior Writer 340B Report Views

California-based drugmaker Amgen on Tuesday announced it was exempting Oregon providers from its 340B contract pharmacy restrictions—but removed a prior [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

HRSA’s Request for Information on 340B Rebates Draws Mixed Reactions from 340B Hospitals, Other Stakeholders

State Contract Pharmacy Roundup: Actions in Maryland, Vermont and New Mexico